Ypsomed Holding AG (XSWX:YPSN) Notes Receivable: CHF0.0 Mil (As of Mar. 2026)


XSWX:YPSN Ypsomed Holding AG XSWX:YPSN
92 GF Score
Price CHF360.60
GF Value CHF397.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Ypsomed Holding AG Notes Receivable?

Ypsomed Holding AG XSWX:YPSN -0.66% 92 Notes Receivable is CHF0.0 Mil as of Mar. 2026. GuruFocus rates XSWX:YPSN with a GF Score™ of 92/100 and a GF Value™ of CHF397.15 (Fairly Valued). The stock has 4 warning signs investors should review.

Ypsomed Holding AG's Notes Receivable for the quarter that ended in Mar. 2026 was CHF0.0 Mil.

Ypsomed Holding AG Notes Receivable Related Terms

Ypsomed Holding AG Notes Receivable Historical Data

* Premium members only.

The historical data trend for Ypsomed Holding AG's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG Notes Receivable Chart

Ypsomed Holding AG Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Ypsomed Holding AG Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:YPSN
92GF Score
Ypsomed Holding AG XSWX:YPSN
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ypsomed Holding AG Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of CHF0.0 Mil mean?
Ypsomed Holding AG (XSWX:YPSN) has a Notes Receivable of CHF0.0 Mil as of Mar. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Ypsomed Holding AG and its competitors.
Is Ypsomed Holding AG's Notes Receivable too high?
Ypsomed Holding AG's current Notes Receivable is CHF0.0 Mil. Overall, Ypsomed Holding AG has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Ypsomed Holding AG's Notes Receivable compare to ISRG and BDX?
Ypsomed Holding AG's Notes Receivable of CHF0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Devices & Instruments company?
A good Notes Receivable depends on the Medical Devices & Instruments industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Ypsomed Holding AG and its competitors. Ypsomed Holding AG's current Notes Receivable is CHF0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ypsomed Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Ypsomed Holding AG (XSWX:YPSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF397.15, compared to a current price of CHF360.60 — trading 9.2% below its estimated fair value. The current Notes Receivable is CHF0.0 Mil. Ypsomed Holding AG's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Ypsomed Holding AG (XSWX:YPSN), the current Notes Receivable is CHF0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ypsomed Holding AG (XSWX:YPSN) Overvalued in 2026?

Based on GuruFocus' analysis, Ypsomed Holding AG stock appears to be undervalued. The current stock price of CHF360.60 is trading 9.2% below its estimated GF Value™ of CHF397.15. GuruFocus considers Ypsomed Holding AG to be Fairly Valued.

Key valuation signals for XSWX:YPSN:

  • Notes Receivable: CHF0.0 Mil
  • GF Value™: CHF397.15 vs. price of CHF360.60 (9.2% below fair value)
  • GF Score™: 92/100 with 4 warning signs

No single metric tells the full story. See the XSWX:YPSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ypsomed Holding AG Business Description

Other Exchanges YPSNz:UK0QLQ:UKOWX:Germany
Address Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a click-on function. The company operates under two reportable segments: Ypsomed Delivery Systems and Ypsomed Diabetes Care.
92GF Score

Get the complete analysis for XSWX:YPSN

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF360.60
Price
CHF397.15
GF Value